Patient Perspectives of Barriers and Facilitators for the Uptake of Pharmacogenomic Testing in Veterans Affairs’ Pharmacogenomic Testing for the Veterans (PHASER) Program

Public Deposited
Analytics

Downloadable Content

Download PDF
Request Version for Screen Reader
Creator
  • Melendez, Karina
    • Other Affiliation: University of Wisconsin
  • Gutierrez-Meza, Diana
    • Other Affiliation: University of Wisconsin
  • Gavin, Kara L.
    • Other Affiliation: University of Wisconsin
  • Alagoz, Esra
    • Other Affiliation: University of Wisconsin
  • Sperber, Nina
    • Other Affiliation: Duke University
  • Wu, Rebekah Ryanne
    • Other Affiliation: Duke University
  • Silva, Abigail
    • Other Affiliation: Loyola University Chicago
  • Pati, Bhabna
    • Other Affiliation: University of Wisconsin
  • Voora, Deepak
    • Other Affiliation: Duke University
  • Hung, Allison
    • Other Affiliation: University of Wisconsin
  • Roberts, Megan C.
    • Affiliation: Eshelman School of Pharmacy
  • Voils, Corrine I.
    • Other Affiliation: University of Wisconsin
Abstract
  • We applied implementation science frameworks to identify barriers and facilitators to veterans’ acceptance of pharmacogenomic testing (PGx), which was made available as a part of clinical care at 25 VA medical centers. We conducted 30 min interviews with veterans who accepted (n = 14), declined (n = 9), or were contemplating (n = 8) PGx testing. Six team members coded one transcript from each participant group to develop the codebook and finalize definitions. Three team members coded the remaining 28 transcripts and met regularly with the larger team to reach a consensus. The coders generated a matrix of implementation constructs by testing status to identify the similarities and differences between accepters, decliners, and contemplators. All groups understood the PGx testing procedures and possible benefits. In the decision-making, accepters prioritized the potential health benefits of PGx testing, such as reducing side effects or the number of medications. In contrast, decliners prioritized the possibilities of data breach or the negative impact on healthcare insurance or Veterans Affairs benefits. Contemplators desired to speak to a provider to learn more before making a decision. Efforts to improve the clarity of data security and the impact on benefits may improve veterans’ abilities to make more informed decisions about whether to undergo PGx testing.
Date of publication
Keyword
DOI
Identifier
Resource type
  • Article
License
  • Attribution 4.0 International
Journal title
  • Journal of Personalized Medicine
Journal volume
  • 13
Journal issue
  • 9
Page start
  • 1367
Language
  • English
Version
  • Publisher
ISSN
  • 2075-4426
Publisher
  • MDPI

Relations

Parents:

This work has no parents.

In Collection:

Items

Thumbnail Title Date Uploaded Visibility Actions
file details jpm-13-01367.pdf 2023-10-06 Public Download